Ferriprox and Epilepsy aggravated - a phase IV clinical study of FDA data

Summary:

Epilepsy aggravated is reported only by a few people who take Ferriprox.

The phase IV clinical study analyzes which people take Ferriprox and have Epilepsy aggravated. It is created by eHealthMe based on reports of 1,327 people who have side effects while taking Ferriprox from the FDA, and is updated regularly.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.

On Mar, 24, 2023

1,327 people reported to have side effects when taking Ferriprox.
Among them, 2 people (0.15%) have Epilepsy aggravated.

What is Ferriprox?

Ferriprox has active ingredients of deferiprone. eHealthMe is studying from 1,331 Ferriprox users for its effectiveness, alternative drugs and more.

What is Epilepsy aggravated?

Epilepsy aggravated (serious common and diverse set of chronic neurological disorders characterized by seizures) is found to be associated with 1,096 drugs and 371 conditions by eHealthMe.

Number of Ferriprox and Epilepsy aggravated reports submitted per year:

Could Ferriprox cause Epilepsy aggravated?

Time on Ferriprox when people have Epilepsy aggravated *:

Gender of people who have Epilepsy aggravated when taking Ferriprox *:

female: 100 %
male: 0.0 %

Age of people who have Epilepsy aggravated when taking Ferriprox *:

Common conditions people have *:

Iron Overload: 1 person, 50.00%
Anaemia (lack of blood): 1 person, 50.00%

* Approximation only. Some reports may have incomplete information.

Do you take Ferriprox and have Epilepsy aggravated?

Check whether Epilepsy aggravated is associated with a drug or a condition

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.

Related studies

How severe was Epilepsy aggravated and when was it recovered:

Epilepsy aggravated in Ferriprox

Expand to all the drugs that have ingredients of deferiprone:

Epilepsy aggravated and drugs with ingredients of deferiprone

Alternative drugs to, pros and cons of Ferriprox:

Ferriprox (1,331 reports)

Common Ferriprox side effects:

Agranulocytosis (a deficiency of granulocytes in the blood, causing increased vulnerability to infection): 208 reports
Death: 111 reports

Browse all side effects of Ferriprox:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Epilepsy aggravated treatments and more:

Epilepsy aggravated (695 reports)

COVID vaccines that are related to Epilepsy aggravated:

Common drugs associated with Epilepsy aggravated:

All the drugs that are associated with Epilepsy aggravated:

Epilepsy aggravated (1,096 drugs)

Common conditions associated with Epilepsy aggravated:

All the conditions that are associated with Epilepsy aggravated:

Epilepsy aggravated (371 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on deferiprone (the active ingredients of Ferriprox) and Ferriprox (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.